These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1274 related articles for article (PubMed ID: 26613280)

  • 1. Correlation of quality of life and functional outcome measures for cervical spondylotic myelopathy.
    Lubelski D; Alvin MD; Nesterenko S; Sundar SJ; Thompson NR; Benzel EC; Mroz TE
    J Neurosurg Spine; 2016 Mar; 24(3):483-9. PubMed ID: 26613280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional outcome instruments used for cervical spondylotic myelopathy: interscale correlation and prediction of preference-based quality of life.
    Whitmore RG; Ghogawala Z; Petrov D; Schwartz JS; Stein SC
    Spine J; 2013 Aug; 13(8):902-7. PubMed ID: 23523443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of life outcomes following cervical decompression for coexisting Parkinson's disease and cervical spondylotic myelopathy.
    Xiao R; Miller JA; Lubelski D; Alberts JL; Mroz TE; Benzel EC; Krishnaney AA; Machado AG
    Spine J; 2016 Nov; 16(11):1358-1366. PubMed ID: 27496286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of dynamic alignment, motion, and center of rotation on myelopathy grade and regional disability in cervical spondylotic myelopathy.
    Liu S; Lafage R; Smith JS; Protopsaltis TS; Lafage VC; Challier V; Shaffrey CI; Radcliff K; Arnold PM; Chapman JR; Schwab FJ; Massicotte EM; Yoon ST; Fehlings MG; Ames CP
    J Neurosurg Spine; 2015 Dec; 23(6):690-700. PubMed ID: 26315953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ancillary outcome measures for assessment of individuals with cervical spondylotic myelopathy.
    Kalsi-Ryan S; Singh A; Massicotte EM; Arnold PM; Brodke DS; Norvell DC; Hermsmeyer JT; Fehlings MG
    Spine (Phila Pa 1976); 2013 Oct; 38(22 Suppl 1):S111-22. PubMed ID: 23963009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychometric properties of the modified Japanese Orthopaedic Association scale in patients with cervical spondylotic myelopathy.
    Kopjar B; Tetreault L; Kalsi-Ryan S; Fehlings M
    Spine (Phila Pa 1976); 2015 Jan; 40(1):E23-8. PubMed ID: 25341993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arthroplasty for cervical spondylotic myelopathy: similar results to patients with only radiculopathy at 3 years' follow-up.
    Fay LY; Huang WC; Wu JC; Chang HK; Tsai TY; Ko CC; Tu TH; Wu CL; Cheng H
    J Neurosurg Spine; 2014 Sep; 21(3):400-10. PubMed ID: 24926929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the minimum clinically important difference in neurological function and quality of life after surgery in cervical spondylotic myelopathy patients: a prospective cohort study.
    Zhou F; Zhang Y; Sun Y; Zhang F; Pan S; Liu Z
    Eur Spine J; 2015 Dec; 24(12):2918-23. PubMed ID: 26324283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative magnetic resonance imaging is associated with baseline neurological status and can predict postoperative recovery in patients with cervical spondylotic myelopathy.
    Arvin B; Kalsi-Ryan S; Mercier D; Furlan JC; Massicotte EM; Fehlings MG
    Spine (Phila Pa 1976); 2013 Jun; 38(14):1170-6. PubMed ID: 23462574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myelopathic signs and functional outcome following cervical decompression surgery: a proposed myelopathy scale.
    El-Zuway S; Farrokhyar F; Kachur E
    J Neurosurg Spine; 2016 Jun; 24(6):871-7. PubMed ID: 26849710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of surgical outcome in cervical spondylotic myelopathy.
    Karpova A; Arun R; Davis AM; Kulkarni AV; Massicotte EM; Mikulis DJ; Lubina ZI; Fehlings MG
    Spine (Phila Pa 1976); 2013 Mar; 38(5):392-400. PubMed ID: 23448898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do quantitative magnetic resonance imaging parameters correlate with the clinical presentation and functional outcomes after surgery in cervical spondylotic myelopathy? A prospective multicenter study.
    Karpova A; Arun R; Kalsi-Ryan S; Massicotte EM; Kopjar B; Fehlings MG
    Spine (Phila Pa 1976); 2014 Aug; 39(18):1488-97. PubMed ID: 24859570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What predicts the best 24-month outcomes following surgery for cervical spondylotic myelopathy? A QOD prospective registry study.
    Chan AK; Park C; Shaffrey CI; Gottfried ON; Than KD; Bisson EF; Bydon M; Asher AL; Coric D; Potts EA; Foley KT; Wang MY; Fu KM; Virk MS; Knightly JJ; Meyer S; Park P; Upadhyaya CD; Shaffrey ME; Buchholz AL; Tumialán LM; Turner JD; Michalopoulos G; Sherrod BA; Agarwal N; Chou D; Haid RW; Mummaneni PV
    J Neurosurg Spine; 2024 Apr; 40(4):453-464. PubMed ID: 38181405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Clinical Prediction Rule for Functional Outcomes in Patients Undergoing Surgery for Degenerative Cervical Myelopathy: Analysis of an International Prospective Multicenter Data Set of 757 Subjects.
    Tetreault L; Kopjar B; Côté P; Arnold P; Fehlings MG
    J Bone Joint Surg Am; 2015 Dec; 97(24):2038-46. PubMed ID: 26677238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anterior versus posterior surgical approaches to treat cervical spondylotic myelopathy: outcomes of the prospective multicenter AOSpine North America CSM study in 264 patients.
    Fehlings MG; Barry S; Kopjar B; Yoon ST; Arnold P; Massicotte EM; Vaccaro A; Brodke DS; Shaffrey C; Smith JS; Woodard E; Banco RJ; Chapman J; Janssen M; Bono C; Sasso R; Dekutoski M; Gokaslan ZL
    Spine (Phila Pa 1976); 2013 Dec; 38(26):2247-52. PubMed ID: 24108289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of life assessment after central corpectomy for cervical spondylotic myelopathy: comparative evaluation of the 36-Item Short Form Health Survey and the World Health Organization Quality of Life-Bref.
    Thakar S; Christopher S; Rajshekhar V
    J Neurosurg Spine; 2009 Oct; 11(4):402-12. PubMed ID: 19929335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the Japanese Orthopaedic Association (JOA) score and modified JOA (mJOA) score for the assessment of cervical myelopathy: a multicenter observational study.
    Kato S; Oshima Y; Oka H; Chikuda H; Takeshita Y; Miyoshi K; Kawamura N; Masuda K; Kunogi J; Okazaki R; Azuma S; Hara N; Tanaka S; Takeshita K
    PLoS One; 2015; 10(4):e0123022. PubMed ID: 25837285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of five scoring systems for cervical spondylogenic myelopathy.
    Dalitz K; Vitzthum HE
    Spine J; 2019 Feb; 19(2):e41-e46. PubMed ID: 18774750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Nurick grading system and modified Japanese Orthopaedic Association scoring system in evaluation of patients with cervical spondylotic myelopathy.
    Revanappa KK; Rajshekhar V
    Eur Spine J; 2011 Sep; 20(9):1545-51. PubMed ID: 21424591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mild diabetes is not a contraindication for surgical decompression in cervical spondylotic myelopathy: results of the AOSpine North America multicenter prospective study (CSM).
    Arnold PM; Fehlings MG; Kopjar B; Yoon ST; Massicotte EM; Vaccaro AR; Brodke DS; Shaffrey CI; Smith JS; Woodard EJ; Banco RJ; Chapman JR; Janssen ME; Bono CM; Sasso RC; Dekutoski MB; Gokaslan ZL
    Spine J; 2014 Jan; 14(1):65-72. PubMed ID: 23981820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 64.